Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 6,135  205.00  3.23%   
About 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Teva Pharmaceutical To Rally Around 58 Here Are 10 Top Analyst Forecasts For Monday - MSN
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical To Rally Around 58 Here Are 10 Top Analyst Forecasts For Monday - Mohawk Industr...
Google News at Macroaxis
over six months ago at news.google.com         
ZTS 3 Growth Pharma Stocks to Guard Your Portfolio - StockNews.com
Google News at Macroaxis
over six months ago at news.google.com         
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Ltd is lower by 0.96 percent Friday In Premarket Trading - InvestorsO...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries isnt out of the woods yet - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Teva Stock Gains. The Company Will Divest Drug Ingredients Business. - Barrons
Google News at Macroaxis
over six months ago at news.google.com         
294163 Shares in Teva Pharmaceutical Industries Limited Acquired by Los Angeles Capital ... - Market...
Google News at Macroaxis
over six months ago at news.google.com         
Technical Pivots with Risk Controls - Stock Traders Daily
Google News at Macroaxis
over six months ago at news.google.com         
Unveiling Teva Pharmaceutical Industries Ltd. Q4 Outlook Wall Street Estimates for Key Metrics - Yah...
Google News at Macroaxis
over six months ago at news.google.com         
Zacks Research Comments on Teva Pharmaceutical Industries Limiteds Q4 2024 Earnings - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Rating Increased to Buy at Jefferies Financial Group - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Bank Pictet Cie Europe AG Invests 13.77 Million in Teva Pharmaceutical Industries Limited - MarketBe...
Google News at Macroaxis
over six months ago at news.google.com         
Investment Analysis - Stock Traders Daily
Google News at Macroaxis
over six months ago at news.google.com         
Yelin Lapidot Holdings Management Ltd. Invests 5.51 Million in Teva Pharmaceutical Industries Limite...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bonds Directory
Find actively traded corporate debentures issued by US companies